Baird Medical expands global presence of microwave ablation technology

Baird Medical (BDMD) announced a milestone in its international expansion. The FDA has issued a Certificate to Foreign Government to the Egyptian regulatory authorities, affirming the company’s compliance with U.S. medical device standards and facilitating its market entry into Egypt. Simultaneously, Baird Medical has formally submitted regulatory registration applications in Egypt, Hong Kong, Thailand, Malaysia, Kazakhstan, Sri Lanka, and India. The company anticipates timely approvals in these markets. This follows the regulatory approval in Indonesia in March. In preparation for market entry, Baird Medical has initiated partnerships with healthcare institutions across these regions to establish distribution networks and conduct training programs on microwave ablation procedures. Microwave ablation is a minimally invasive procedure widely used in the treatment of thyroid nodules and tumors.